Evidence map›Paper›PMID 32432118›Full record

SynthesisFrontiers in medicine2020

The Quality of Clinical Practice Guidelines and Consensuses on the Management of Primary Aldosteronism: A Critical Appraisal.

Zhe Meng, Liang Zhou, Zhe Dai, Chang Xu, Guofeng Qian, Mou Peng, Yuchun Zhu, Joey S W Kwong, Xinghuan Wang

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhe MengDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Liang ZhouDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Zhe DaiDepartment of Adrenal Hypertension, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Chang XuChinese Evidence Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
Guofeng QianDepartment of Urology, The First Hospital of Zhejiang University, Zhejiang University, Hangzhou, China.
Mou PengDepartment of Urology, The Second Hospital of Xiangya, Zhongnan University, Hangzhou, China.
Yuchun ZhuDepartment of Adrenal Hypertension, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Joey S W KwongJC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Xinghuan WangDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AGREE IIclinical practice guidelineprimary aldosteronismquality assessmentsystematic review

Identifiers

PMID32432118
PMCPMC7214671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.